Page 12 - Betesil-12pp-V3
P. 12

2.250 mg medicated plaster
                            Betamethasone valerate

          The only medicated plaster containing a potent steroid that treats,
            protects, and provides a metered dose for inflammatory skin
                          conditions and plaque psoriasis. (1)













                                      How Often?
                                      1 plaster per plaque every 24 hours
                                      How Many?
                                      6 plasters/day maximum
                                      Secure?
                                      Adhesive strips included for securing dressings
                                      What’s in the pack?
                                      Box of 4 or 8 medicated plasters (10 x 7.5 cm)
                                      Maximum Treatment?
                                      30 days until plaque improves, then if needed continue
                                      treatment with a less potent corticosteroid


          (1) Derma UK Ltd., ‘Summary of Betesil  Product Characteristics (SmPC).’ 2021
                              ®
          (2) Naldi L et al., ‘Efficacy and Safety of the Betamethasone Valerate 0,1% Plaster in Mild-to-Moderate Chronic Plaque
          Psoriasis: A Randomized, Parallel-Group, Active-Controlled, Phase III Study.’ American Journal of Clinical Dermatology, vol. 12,
          no 3, 2011, pp. 191-2011.
          (3) Pacifico A et al., ‘A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of
          mild to moderate psoriasis.’ Journal of European Academy of Dermatology and Venereology, no 20, 2006, pp. 153-157.
          (4) Ortonne JP, et al., ‘Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in
          the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre
          trial.’ Journal of European Academy of Dermatology and Venereology, vol. 28, no 9, 2014, pp. 1226-34.
                                (5) National Institute for Health and Care Excellence, Topical corticosteroids,
                                National Institute for Health and Care Excellence, https://bnf.nice.org.uk/treatment-
                                summary/topical-corticosteroids.html, (accessed 24th November 2021).

          2.250 mg medicated plaster
         Betamethasone valerate   BET/82/1121                            Date of preparation: December 2021.
   7   8   9   10   11   12